glp 1 ra drugs Indications for GLP-1/GIP Summary Sheet and Beyond! Market Overview: GLP-1 Agonists and
Description
2025 Mar 6;135(9):e188314
Another meta-analysis including 43 trials ( n = 68,775) and 12 observational studies ( n = 1,777,358) concluded that the relative effect of DPP-4i as a class on HF in T2DM patients is uncertain
[DOI] [PubMed] [Google Scholar] 66.Zhao H-J, Jiang X, Hu L-J, Yang L, Deng L-D, Wang Y-P, et al
NICE guidelines recommend GLP-1 receptor agonists for specific patient populations with type 2 diabetes
doi: 10.1016/S0140-6736(21)01443-4 [DOI] [PubMed] [Google Scholar] 193.Del Prato S, Kahn SE, Pavo I, et al
GLP-1 medications lower them
